Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
2-(Beta-D-glucopyranosyl)-5-methyl-1,3,4-benzothiazole is a synthetic small molecule with the chemical formula C14H17NO5S and a molecular weight of approximately 311.36 g/mol[1][2][6]. It features a benzothiazole core substituted at the 2-position with a beta-D-glucopyranosyl group and at the 5-position with a methyl group. The compound is listed as an experimental pharmaceutical in chemical databases but lacks detailed information on its mechanism of action or clinical use. It has been referenced in structure–activity relationship studies involving glucopyranosyl azole derivatives as potential enzyme inhibitors[5]. No approved therapeutic indications or marketed products are currently associated with this molecule.
- Other names
- 2-(BETA-D-GLUCOPYRANOSYL)-5-METHYL-1,3,4-BENZOTHIAZOLE(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(5-methyl-1,3-benzothiazol-2-yl)oxane-3,4,5-triol
02
Targets
PYGM (Glycogen phosphorylase, muscle form)
Beyond the preview
Go deeper on 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole.